Atlas Trials

A Study of Paliperidone Palmitate 6-Month Formulation

Clinical trial NCT04072575 · COMPLETED

Trial details

NCT number
NCT04072575
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2019-09-19
Primary completion
2022-05-03
Enrollment
178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.